In the course of a phase I trial, in which recombinant IL-2 (rlL-2) was infused intraperitoneally (i.p.) in patients with peritoneal carcinomatosis, we evaluated the effect on "tumorassociated lymphocytes" (TAL) isolated from the axitic fluid. No major changes in the percentages of cells expressing
Intraperitoneal infusion of interleukin-2 in patients with malignant ascites: Phenotypic and functional effects on tumor-associated lymphocytes
โ Scribed by Melioli, Giovanni ;Baldini, Editta ;Maria, Andrea ;Moretta, Lorenzo
- Publisher
- Springer-Verlag
- Year
- 1988
- Weight
- 343 KB
- Volume
- 18
- Category
- Article
- ISSN
- 0390-5748
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
## Abstract Eight ovarian cancer patients with ascites resistant to various chemotherapy protocols were treated i.p. with __C. parvum__ in an effort to obtain a palliative reduction of peritoneal effusions. __C. parvum__(7โ14 mg) was given i.p. on days 0, 7, 28 and then at monthly intervals. Three
Natural killer (NK) cells and NK cell activity were determined in three groups (newly diagnosed [n = 211, on therapy [n = 211, and off therapy [n = 181) of children with various types of malignant solid tumors and in a control group (n = 26) by means of Leu-7 and Leu-llb monoclonal antibodies and a